Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Total flavonoids of litchi seed (TFLS) refers to the complex mixture of bioactive flavonoid compounds extracted from the seeds of Litchi chinensis. These extracts are rich in various types of flavonoids, including but not limited to liquiritigenin, apigenin, naringenin, luteolin, dihydrokaempferol, daidzein, quercetin, taxifolin, kaempferol, isorhamnetin, myricetin, catechin and their glycosides such as rutin and baicalin[2][4][5]. TFLS has demonstrated broad-spectrum antitumor activities in preclinical studies. It inhibits proliferation and metastasis while inducing apoptosis in cancer cells—particularly prostate and breast cancer cell lines—by modulating pathways related to epithelial-mesenchymal transition (EMT), apoptosis (e.g., upregulation of E-cadherin and Bax; downregulation of Vimentin and Bcl-2), and stemness properties[3][4][7]. The extract is typically obtained via solvent extraction followed by purification steps such as column chromatography or HPLC. While traditionally used in Chinese medicine for urologic neoplasms including prostate cancer[4], its precise mechanism involves multiple molecular targets associated with tumor growth suppression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on total flavonoids of litchi seed.